Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
1 this month

Showing 7641–7660 of 17,529 recalls

March 12, 2019· MSM Nutraceuticals, LLC

Recalled Item: Dry Eye

The Issue: Lack of Assurance of Sterility: Product is not

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 12, 2019· MSM Nutraceuticals, LLC

Recalled Item: Dr. Berne's MSM DROPS 15% Solution

The Issue: Lack of Assurance of Sterility: Product is not

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 12, 2019· MSM Nutraceuticals, LLC

Recalled Item: 15% MSM

The Issue: Lack of Assurance of Sterility: Product is not

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 12, 2019· Akorn Inc

Recalled Item: Hydrocortisone and Acetic Acid Otic Solution

The Issue: Sub Potent Drug: OOS results observed for the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 11, 2019· Iso-Tex Diagnostics, Inc

Recalled Item: Volumex (Iodinated I 131 Albumin) Injection USP

The Issue: Lack of Assurance of Sterility: preliminary environmental monitoring

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 11, 2019· Teva Pharmaceuticals USA

Recalled Item: Lansoprazole Delayed-Release Orally Disintegrating Tablets

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 8, 2019· PD-Rx Pharmaceuticals, Inc.

Recalled Item: Losartan Potassium USP

The Issue: CGMP deviation: Product found to contain trace amounts

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 7, 2019· Rising Pharmaceuticals, Inc.

Recalled Item: Valsartan Tablets 320 mg USP

The Issue: CGMP Deviations; Detection of a trace amount of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 7, 2019· Rising Pharmaceuticals, Inc.

Recalled Item: Valsartan Tablets 40 mg USP

The Issue: CGMP Deviations; Detection of a trace amount of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 7, 2019· Rising Pharmaceuticals, Inc.

Recalled Item: Valsartan Tablets 80 mg USP

The Issue: CGMP Deviations; Detection of a trace amount of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 7, 2019· Rising Pharmaceuticals, Inc.

Recalled Item: Valsartan Tablets 160 mg USP

The Issue: CGMP Deviations; Detection of a trace amount of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 7, 2019· Boehringer Ingelheim Pharmaceuticals, Inc.

Recalled Item: Mirapex (pramipexole dihydrochloride) Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 7, 2019· Medtech Products, Inc.

Recalled Item: Little Remedies New Baby Essentials Kit. Each kit contains 1

The Issue: Undeclared Excipients

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 6, 2019· American Health Packaging

Recalled Item: Valsartan Tablets USP 160 mg

The Issue: CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 6, 2019· Preferred Pharmaceuticals, Inc

Recalled Item: Losartan Potassium Tablets

The Issue: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 6, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Docetaxel Injection USP

The Issue: Defective Container: complaint for seal and cap vial

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 5, 2019· USA LESS Inc.

Recalled Item: LEOPARD Miracle Honey packaged in a wooden box

The Issue: Undeclared Sildenafil

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 5, 2019· AVKARE Inc.

Recalled Item: Losartan Potassium and Hydrochlorothiazide Tablets

The Issue: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 5, 2019· AVKARE Inc.

Recalled Item: Losartan Potassium Tablets USP 50 mg 50 Tablets (5x10) Unit Dose boxes

The Issue: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 5, 2019· AVKARE Inc.

Recalled Item: Losartan Potassium and Hydrochlorothiazide Tablets

The Issue: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund